Local News: Seattle, WA 

 | 

Sign Up

 | 

Sign In

Bristol Myers Squibb News Editors

News Widget

Display the Bristol Myers Squibb news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Bristol Myers Squibb News

News on Bristol Myers Squibb (Ticker: BMY) continually updated from thousands of sources around the net.

3 hrs ago | Live Charts

FTSE 100 movers: RBS makes strong gains on Numis note

Royal Bank of Scotland was in the lead after Numis raised its target price from 308p to 410p, while upgrading the stock to buy.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

13 hrs ago | China Daily

Chinese pharma companies look West

Zhejiang Hisun Pharmaceutical Co's pavilion at a fair in Beijing. By setting up a joint venture with US-based Pfizer Inc in September, Hisun made a breakthrough in China's pharmaceutical industry by taking a controlling stake in the JV with Pfizer, the world's largest drug-maker by sales.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Pharmaceuticals, Marketing

Fri May 17, 2013

The Jersey Journal

Bristol-Myers Squibb drug study showed effectiveness against advanced melanoma cancer

Two drugs from Bristol-Myers Squibb Co. shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals, Oncology

Wed May 15, 2013

The Washington Post

Bristol-Myers Drug Cocktail Quells Melanoma Tumors, Study Finds

Two drugs from Bristol-Myers Squibb Co. shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Oncology, Memorial SloanKettering Cancer Center, Hospital Administration, Whitehouse Station, NJ, Health, Lung Cancer

Reuters

Bristol-Myers shares jump ahead of melanoma trial data

Bristol-Myers shares were up 5.1 percent at $44.35 shortly before the close on Wednesday, in their busiest day of trading since August.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Oncology

Corporate Counsel

Bristol-Myers Squibb: The Caped Crusaders

Bristol-Myers Squibb's Joseph Campisi and Demetrios Kyonieus were virtually inseparable for eight months in 2012 while they negotiated an M&A deal that was large and complex.

Comment?

Related Topix: Bristol Myers Squibb, Bristol-Myers Squibb, Biotech, Bloomsbury Publishing, Media, Publishing, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Hurricane, Weather, Hurricane Sandy

Tue May 14, 2013

Freshnews

Bristol-Myers Squibb to Present at UBS Global Health Care Conference

Bristol-Myers Squibb Company will present at the UBS Global Health Care Conference on Tuesday, May 21, 2013, in New York City.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals

The Motley Fool

Should You Buy Stock in Gilead After the Earnings Miss?

The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... ) reported a relatively rare earnings miss in the first quarter on May 2. The biotech announced earnings of $0.48 per share while analysts were expecting $0.50 per share.

Comment?

Related Topix: Financial Markets, HIV/AIDS, Health, Biotech, Medicine, Healthcare Industry

SchaeffersResearch.com

Midday Market Stats: Dow Jones Industrial Average, S&P 500 Jump to Record Intraday Peaks

The Dow Jones Industrial Average is up 74 points, or 0.5%, to 15,165.81 , boosted by positive comments made by David Tepper this morning.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Day Trading, Financial Markets, Personal Finance

Mon May 13, 2013

JD Supra

Court Report - May 12, 2013

Bristol-Myers Squibb Co. v. Genentech, Inc. et al. 3:13-cv-02045; filed May 3, 2013 in the Northern District of California Declaratory judgment of invalidity, unenforceability, and noninfringement of of U.S. Patent Nos.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Genentech, Startups

The Motley Fool

Buying the Pharma Dips

Marshall is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.

Comment?

Related Topix: Blog News, Biotech, Medicine, Healthcare Industry

Business Wire

Research and Markets: Bristol-Myers Squibb Partnering 2005-2013

This report provides all the information you require to better understand Bristol-Myers Squibb and its partnering interests and activities over the past seven years.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry

Freshnews

Bas Burger To Lead BT Operations In The US & Canada And Across Global Industry Sectors

BT announced the appointment of Bas Burger to the position of president of BT US & Canada and president for the Global Consumer Packaged Goods and the Global Pharmaceutical and Chemical industry sectors.

Comment?

Related Topix: Telecom, BT Group, Unilever, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medicine, Pharmaceuticals, Healthcare Industry

Customer Interaction Solutions

RBCC Partner n3D Signs U.S. Distribution Agreement

Rainbow Coral Corp. received word this week that the revolutionary technology developed by its partner, Nano3D Biosciences , is set to begin penetrating the U.S. marketplace.

Comment?

Related Topix: Biotech, Science / Technology, Marketing, Medicine, Healthcare Industry, Amgen

Sun May 12, 2013

Bloomberg

Immune-Boosting Cancer Drugs Seen Extending Lives Along With Sales: Health

Merck & Co. , Bristol-Myers Squibb Co. and Roche Holding AG have opened a new front against cancer with the next generation of experimental drugs that use the human immune system to seek and destroy tumor cells.

Comment?

Related Topix: Medicine, Cancer, Health, Biotech, Merck , Healthcare Industry, Oncology, Genetics

Sat May 11, 2013

PR-inside.com

Just Released: "Bristol-Myers Squibb Company (BMY) - Financial and Strategic SWOT Analysis Review"

Bristol-Myers Squibb Company is global biopharmaceutical company. It undertakes the discovery, development, licensing, manufacture, marketing and distribution of biopharmaceuticals and related healthcare products.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing

Fri May 10, 2013

The Motley Fool

6 Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part I

The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Diabetes, Health

Thu May 09, 2013

BioSpace

Adaptive Biotechnologies Signs Biomarker Discovery Collaboration...

Under the collaboration, Adaptive will use its proprietary immune profiling assay, immunoSEQ, to identify potential biomarkers that may inform about drug response.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Oncology

Wed May 08, 2013

BioSpace

Bristol-Myers Squibb Company to Present at Bank of America Merrill Lynch Health Care Conference

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Bristol-Myers Squibb Company will present at Bank of America Merrill Lynch Health Care Conference on Wednesday, May 15, 2013, in Las Vegas.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Minyanville

In Danish Laboratories, Hope Looms Large for a Permanent HIV Cure

So far HIV has eluded a permanent cure, yet many newly diagnosed patients can now control the virus with just one pill per day.

Comment?

Related Topix: HIV/AIDS, Health, Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, Merck , Vaccine Company

Seattle Jobs